Prot# TTX404: A Phase 3, Multicenter, Randomized Study To Evaluate The Substitution Of Marqibo (Vincristine Sulfate Liposomes Injection, VSLI) For Standard Vincristine Sulfate Injection (VSI) In The Induction, Intensification, And Maintenance Phases Of Co

Project: Research project

Project Details

StatusFinished
Effective start/end date8/7/128/7/18

Funding

  • Talon Therapeutics, Inc (TTX404)